Market Trends of Bladder Scanners Industry
Portable Bladder Scanners Segment is Expected to Hold a Significant Market Share
Portable bladder scanners are ultrasound devices that use automated technology to register bladder volume digitally, including post-void residual (PVR) volume, and provide three-dimensional images of the bladder.
The major advantage of the portable ultrasound bladder scanner is to be a user-friendly diagnostic procedure with high-end accuracy. Another main benefit of a portable bladder ultrasound scanner is its portability, reliability, cost-effectiveness, and non-invasiveness. The increased occurrence of cancer related to the urinary tract creates the need for diagnostics and scanning devices, propelling the growth of the market studied. For instance, as per the report published by the American Society of Clinical Oncology (ASCO) in February 2022, around 81,180 adults (61,700 men and 19,480 women) in the United States were diagnosed with bladder cancer 2022. It also stated that smoking accounts for 47.0% of the risk factors for bladder cancer. Furthermore, the report also stated that, in the United States, bladder cancer is the eighth most common cause of death by cancer among men. Thus, the increasing prevalence of bladder cancer is expected to increase the demand for bladder cancer scanners which is expected to increase segmental growth over the forecast period.
The increasing prevalence of urological diseases and the rising preference for portable bladder scanner use are the key factors for the growth of the bladder scanner market. According to a research study published in BMC Geriatrics Journal in March 2021, the study results found that the highest prevalence of urinary incontinence was reported to be 45.1% in older women in Asia. Healthcare professionals (primarily nurses) use the device to measure postvoid residual (PVR) urine volume and prevent unnecessary catheterization, and these products may improve the diagnosis and differentiation of urological problems, which helps in the management and treatment of urological diseases, including the establishment of voiding schedules, the study of bladder biofeedback, fewer urinary tract infections (UTIs), and monitoring of potential urinary incontinence after surgery or trauma.
Therefore, the increasing prevalence of urological diseases and the rising preference for portable bladder scanners are the key factors for the growth of the bladder scanner market.
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the bladder scanner market globally due to the rising prevalence of urological diseases and high healthcare expenditure. New product approvals, the growing prevalence of urological disorders, increasing diagnostic procedures, and increasing utilization of mobile portable ultrasound devices in clinics and hospitals contribute to the growth of the bladder scanners market.
According to the National Institutes of Health data updated in September 2021, chronic kidney disease (CKD) affects nearly one-seventh of all adults in the United States (i.e., 37 million people). The risk of CKD is much higher for Americans with diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of diabetics and one-fifth of those with high blood pressure. Heart disease and a family history of renal failure are two more risk factors for kidney disease.
Additionally, as per the Canadian Institute for Health Information and the Canadian Patient Safety Institute, data updated March 2021, Urinary tract infections (UTIs) are the fifth most common type of healthcare-associated infection, with an estimated 62,700 UTIs in acute care hospitals (US) every year. UTIs account for more than 9.5% of infections reported by acute care hospitals. Hence, increasing chronic diseases led to an increased demand for bladder scanners, which increased the demand for bladder scanners in the region.
Adopting artificial intelligence in the devices helps in better workflow, accuracy, detection, and diagnosis of the disease. The launch of technically advanced products by market players is also augmenting the growth of the market studied. For instance, in June 2021, Verathon released the Bladderscan i10. It is a next-generation bladder volume measuring technology that may empower users with new capabilities that enhance leadership in ease of use and dependability. Additionally, the product safeguards clinical confidence through Imagesense, Verathon's proprietary artificial intelligence deep learning technology.
Hence, due to the aforementioned factors, the bladder scanners market is anticipated to propel over the analysis period in North America.
